Cipher Pharmaceuticals Financial Overview
Cipher Pharmaceuticals's market cap is currently $266.14M. The company's EPS TTM is $0.21; its P/E ratio is 22.20; Cipher Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
